The Cohorts · Quarterly vintage
Inception 2024-04-01 · 2.5 years held
Q2 2024 · Top 5.
On 2024-04-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q2 2024 · Top 5 · since inception
+70.9%
CAGR 24.3% annualised
S&P 500 · since inception
+50.2%
CAGR 17.9% annualised
Spread
+20.7%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | JPM | $188.77 | $5,369.79 | +2638.6% | $349.67 | +85.2% | +17.0% | Read → |
| 2 | BAC | $35.44 | $349.95 | +820.3% | $57.73 | +62.9% | +12.6% | Read → |
| 3 | OXY | $63.26 | $416.91 | +593.2% | $58.84 | -7.0% | -1.4% | Read → |
| 4 | CAT | $352.15 | $1,909.53 | +497.2% | $808.99 | +129.7% | +25.9% | Read → |
| 5 | JNJ | $147.16 | $708.75 | +414.8% | $269.99 | +83.5% | +16.7% | Read → |
Biggest contributors
Where the cohort earned its keep.
- CAT · $352.15 → $808.99+129.7%
- JPM · $188.77 → $349.67+85.2%
- JNJ · $147.16 → $269.99+83.5%
Biggest detractors
Where the protocol got it wrong.
- OXY · $63.26 → $58.84-7.0%